ID   OS1 [Human osteosarcoma]
AC   CVCL_F864
DR   Wikidata; Q54936541
RX   PubMed=18931939;
RX   PubMed=19746444;
CC   Population: Chinese; Singaporian.
CC   Doubling time: ~5 days (PubMed=19746444).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
RX   PubMed=18931939; DOI=10.1007/s11033-008-9378-1; PMCID=PMC2981062;
RA   Nathan S.S., Pereira B.P., Zhou Y.-F., Gupta A., Dombrowski C.,
RA   Soong R., Pho R.W.-H., Stein G.S., Salto-Tellez M., Cool S.M.,
RA   van Wijnen A.J.;
RT   "Elevated expression of Runx2 as a key parameter in the etiology of
RT   osteosarcoma.";
RL   Mol. Biol. Rep. 36:153-158(2009).
//
RX   PubMed=19746444; DOI=10.1002/jcp.21921; PMCID=PMC2768260;
RA   Pereira B.P., Zhou Y.-F., Gupta A., Leong D.T., Aung K.Z., Ling L.,
RA   Pho R.W.-H., Galindo M., Salto-Tellez M., Stein G.S., Cool S.M.,
RA   van Wijnen A.J., Nathan S.S.;
RT   "Runx2, p53, and pRB status as diagnostic parameters for deregulation
RT   of osteoblast growth and differentiation in a new pre-chemotherapeutic
RT   osteosarcoma cell line (OS1).";
RL   J. Cell. Physiol. 221:778-788(2009).
//